Document Detail


Improvement of blood pressure control in a hypertension clinic in Japan: a 15-year follow-up study.
MedLine Citation:
PMID:  19886853     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many guidelines recommended strict blood pressure (BP) control to prevent cardiovascular events. However, BP control in a substantial majority of hypertensives remains to be insufficient. We have determined the trends of BP control of the same patients during 15 years in a hypertension clinic. One hundred three patients (age 32-91, mean 68 +/- 11 years in 2006), who were followed at our hypertension clinic between 1991-2006, were retrospectively investigated. We compared the clinical characteristics of the patients in 2006 to those in 1991, 1996, and 2001, using the averaged BP determined at two occasions of each year for our analysis. The average BP decreased from 144 +/- 17/87 +/- 10 mmHg to 132 +/- 12/75 +/- 10 mmHg (p < 0.01) during the 15 years between 1991 and 2006. When good BP control was defined as < 140/90 mmHg, the rate of patients with good BP control increased from 35% in 1991 to 45% in 1996, to 54% in 2001 (p < 0.01 vs. 1991), and to 72% in 2006 (p < 0.01 vs. 1991). The number of anti-hypertensive drugs used in 2006 significantly increased compared to those in 1991, 1996, and 2001. More specifically, the use of diuretics and alpha-blockers increased significantly during this period. Results suggest that BP control improved in the 15 years studied, and the increased use of the anti-hypertensive drugs, as well as the increased awareness of the importance of strict BP control, seems to have contributed to improve the BP control.
Authors:
Yuko Ohta; Kiyoshi Matsumura; Takuya Tsuchihashi; Toshio Ohtsubo; Hisatomi Arima; Yoshikazu Miwa; Kenichi Goto; Yusuke Ohya; Koji Fujii; Keiko Uezono; Isao Abe; Mitsuo Iida
Related Documents :
8021903 - Number of measurements required for the analysis of diurnal blood pressure profile.
20720213 - Manual and automated office measurements in relation to awake ambulatory blood pressure...
14597863 - Coronary flow reserve in hypertensive patients with appropriate or inappropriate left v...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  31     ISSN:  1525-6006     ISO Abbreviation:  Clin. Exp. Hypertens.     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-11-05     Completed Date:  2010-02-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  553-9     Citation Subset:  IM    
Affiliation:
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. yukoo@kyumed.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Antagonists / therapeutic use
Adrenergic beta-Antagonists / therapeutic use
Aged
Angiotensin II Type 1 Receptor Blockers / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antihypertensive Agents / therapeutic use
Blood Pressure / drug effects
Diuretics / therapeutic use
Follow-Up Studies
Humans
Hypertension / blood,  drug therapy*,  physiopathology*
Japan
Male
Middle Aged
Outpatient Clinics, Hospital
Practice Guidelines as Topic
Renin-Angiotensin System / drug effects
Retrospective Studies
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Antagonists; 0/Adrenergic beta-Antagonists; 0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Diuretics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women ...
Next Document:  Role of heme oxygenase in modulating endothelial function in mesenteric small resistance arteries of...